119 related articles for article (PubMed ID: 30420001)
1. Optimizing patient expectancy in the pharmacologic treatment of major depressive disorder.
Zilcha-Mano S; Brown PJ; Roose SP; Cappetta K; Rutherford BR
Psychol Med; 2019 Oct; 49(14):2414-2420. PubMed ID: 30420001
[TBL] [Abstract][Full Text] [Related]
2. A randomized, prospective pilot study of patient expectancy and antidepressant outcome.
Rutherford BR; Marcus SM; Wang P; Sneed JR; Pelton G; Devanand D; Duan N; Roose SP
Psychol Med; 2013 May; 43(5):975-82. PubMed ID: 22971472
[TBL] [Abstract][Full Text] [Related]
3. Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials.
Zilcha-Mano S; Wang Z; Peterson BS; Wall MM; Chen Y; Wager TD; Brown PJ; Roose SP; Rutherford BR
J Psychiatr Res; 2019 Sep; 116():19-25. PubMed ID: 31176108
[TBL] [Abstract][Full Text] [Related]
4. Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.
Rutherford BR; Wall MM; Brown PJ; Choo TH; Wager TD; Peterson BS; Chung S; Kirsch I; Roose SP
Am J Psychiatry; 2017 Feb; 174(2):135-142. PubMed ID: 27609242
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant study design affects patient expectancy: a pilot study.
Rutherford B; Sneed J; Devanand D; Eisenstadt R; Roose S
Psychol Med; 2010 May; 40(5):781-8. PubMed ID: 19732481
[TBL] [Abstract][Full Text] [Related]
6. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
[TBL] [Abstract][Full Text] [Related]
7. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder.
Hunter AM; Cook IA; Tartter M; Sharma SK; Disse GD; Leuchter AF
Psychopharmacology (Berl); 2015 Oct; 232(20):3833-40. PubMed ID: 26319158
[TBL] [Abstract][Full Text] [Related]
9. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
[TBL] [Abstract][Full Text] [Related]
10. Rumination in patients with major depressive disorder before and after antidepressant treatment.
Segerberg TSS; Ozenne B; Dam VH; Köhler-Forsberg K; Jørgensen MB; Frokjaer VG; Knudsen GM; Stenbæk DS
J Affect Disord; 2024 Sep; 360():322-325. PubMed ID: 38810785
[TBL] [Abstract][Full Text] [Related]
11. Does prior antidepressant treatment of major depression impact brain function during current treatment?
Hunter AM; Cook IA; Leuchter AF
Eur Neuropsychopharmacol; 2012 Oct; 22(10):711-20. PubMed ID: 22445212
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
[TBL] [Abstract][Full Text] [Related]
13. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
Jain FA; Hunter AM; Brooks JO; Leuchter AF
Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
[TBL] [Abstract][Full Text] [Related]
15. The role of late life depressive symptoms on the trajectories of insomnia symptoms during antidepressant treatment.
Gebara MA; Kasckow J; Smagula SF; DiNapoli EA; Karp JF; Lenze EJ; Mulsant BH; Reynolds CF
J Psychiatr Res; 2018 Jan; 96():162-166. PubMed ID: 29069615
[TBL] [Abstract][Full Text] [Related]
16. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Furey ML; Drevets WC
Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
[TBL] [Abstract][Full Text] [Related]
18. Can people with nonsevere major depression benefit from antidepressant medication?
Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
[TBL] [Abstract][Full Text] [Related]
19. Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.
Bauer M; Thase ME; Liu S; Earley W; Eriksson H
J Psychopharmacol; 2015 May; 29(5):565-74. PubMed ID: 25257148
[TBL] [Abstract][Full Text] [Related]
20. The influence of patients' preference/attitude towards psychotherapy and antidepressant medication on the treatment of major depressive disorder.
Moradveisi L; Huibers M; Renner F; Arntz A
J Behav Ther Exp Psychiatry; 2014 Mar; 45(1):170-7. PubMed ID: 24172145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
